Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

The Association of Red Blood Cell Distribution Width to Platelet Count Ratio and 28-Day Mortality of Patients with Sepsis: A Retrospective Cohort Study

Authors Ge S, Lin S, Zhang L, Zeng M

Received 29 June 2020

Accepted for publication 11 September 2020

Published 19 October 2020 Volume 2020:16 Pages 999—1006

DOI https://doi.org/10.2147/TCRM.S268523

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Deyun Wang


Shanhui Ge, Shan Lin, Lishan Zhang, Mian Zeng

Department of Medical Intensive Care Unit, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Institute of Pulmonary Diseases, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China

Correspondence: Mian Zeng
Department of Medical Intensive Care Unit, The First Affiliated Hospital of Sun Yat-sen University, No. 58 Zhongshan Road 2, Guangzhou, Guangdong 510080, People’s Republic of China
Email zengmian@mail.sysu.edu.cn

Background: Sepsis is a life-threatening and inflammatory disease with high morbidity and mortality. Red blood cell distribution width to platelet count ratio (RPR) was known as an inflammatory biomarker and was related to poor outcomes of various diseases.
Aim: This study was intended to explore the association between RPR and mortality of sepsis patients.
Methods: A retrospective cohort study was undertaken in patients with sepsis, and the data were collected from a public database called Medical Information Mart for Intensive Care III (MIMIC-III). The primary outcome was 28-day mortality while the secondary outcomes were 90-day mortality and ICU mortality. Multivariable regression analyses, as well as interaction and stratified analyses, were conducted to investigate the relation between RPR and sepsis mortality.
Results: In total, we enrolled 7531 patients with 1316 deaths. RPR was independently correlated with 28-day mortality (per 0.1 increase: HR=1.04; 95% CI 1.02– 1.06), 90-day mortality (per 0.1 increase: HR=1.04; 95% CI 1.03– 1.06) and ICU mortality (per 0.1 increase: OR=1.06; 95% CI 1.02– 1.10). Twenty-eight-day survival was worse in the high RPR (≥ 0.134) group according to the Kaplan–Meier curve analyses (Log rank test, p< 0.001). In stratified analyses, Sequential Organ Failure Assessment (SOFA) score and length of ICU stay had interactive effects with the high RPR (≥ 0.134) group on 28-day mortality.
Conclusion: RPR is a novel biomarker that indicates poor prognosis of sepsis patients. Clinicians are required to pay more attention to those patients with high RPR.

Keywords: ICU, sepsis, prognosis, inflammatory marker, MIMIC-III

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]